WALLSTENT™ RP Endoprosthesis M001712100Recalls & reported problems
Boston Scientific Corporation · Self-Expanding Stent · Class 3
All models of WALLSTENT RP Endoprosthesis (19)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08714729345671), received between Dec 4, 2019 and Jul 15, 2020 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Activation Failure” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Activation Failure2
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJul 15, 2020Activation Failure; Activation Failure
IT WAS REPORTED THAT THE STENT DID NOT FULL EXPAND, REQUIRING ADDITIONAL INTERVENTION. THE 75% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY CALCIFIED UPPER LEFT ARM AND DIRECTLY ABOVE V SIDE ANASTOMOSIS. A 6.00MM/2.0CM/50CM PERIPHERAL CUTTING BALLOON WAS USED TOGETHER WITH TWO WALLSTENT (8X47X75 AND 7X34X75). THE WALLSTENTS WERE IMPLANTED ON (B)(6) 2020. DURING THE PROCEDURE, THE FIRST WALLSTENT THAT WAS PLACED IN THE MIDDLE PART OF THE UPPER ARM DURING THE PREVIOUS TREATMENT, WAS EXPANDED TO 6 ATM FOR FOUR TIMES WITH A SLIGHT SHIFT FROM THE CENTRAL PART TO THE PERIPHERY EACH TIME. INDENTATION WAS NOT OBTAINED AS CONFIRMED BY CONTRAST IMAGING, THUS ADDITIONAL EXPANSION WAS PERFORMED AT 10 ATM FOR THREE TIMES, SIMILARLY WHILE SHIFTING. AFTER THAT, WITHOUT REMOVING FROM THE SHEATH, THE SECOND WALLSTENT THAT WAS PREVIOUSLY PLACED WAS ON THE ELBOW AND V SIDE ANASTOMOSIS, AND WAS EXPANDED AT 6 LOCATIONS AT 10 ATM IN THE SAME WAY. ALSO, THE CENTRAL SIDE AND THE PERIPHERAL SIDE WITHIN THE STENT ARE EXPANDED ONCE AT 10 ATM. WHEN IMAGING WAS TAKEN OF THE WHOLE ARM FOR THE PURPOSE OF FINAL CONFIRMATION, INCOMPLETE DILATION/EXPANSION WAS OBSERVED IN BOTH THE MIDDLE PART OF THE UPPER A
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10277704 ↗MalfunctionDec 4, 2019Activation Failure; Activation Failure
REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 21-NOV-2019. IT WAS REPORTED THAT DEPLOYMENT DIFFICULTIES OCCURRED. THE STENOSED TARGET LESION WAS LOCATED IN A VENTRICULO-ATRIAL SHUNT. A 7X34X75/ ILIAC 6F UNISTEP PLUS REDUCED PROFILE WALLSTENT WAS ADVANCED BUT FAILED TO DEPLOY. THE DEVICE WAS REMOVED AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED. HOWEVER, RETURNED DEVICE ANALYSIS REVEALED STENT DAMAGE AND DEVICE FRACTURES.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9412545 ↗
Other STENT, ILIAC devices
- Cordis S.M.A.R.T. Control Vascular Stent System C10040MLCordis US Corp. · STENT, ILIAC1 recall3 reports
- Absolute Pro 1012534-100Abbott Vascular Inc. · STENT, ILIAC51 reports
- Protégé™ GPS™ SERB65-09-60-80Ev3, Inc · STENT, ILIAC1 recall0 reports
- Cordis S.M.A.R.T. Control Vascular Stent System C09060MLCordis US Corp. · STENT, ILIAC1 recall0 reports
- Absolute Pro 1012535-100Abbott Vascular Inc. · STENT, ILIAC1 death41 reports
- Omnilink Elite 1012631-39Abbott Vascular Inc. · STENT, ILIAC27 reports
- Omnilink Elite 1012632-29Abbott Vascular Inc. · STENT, ILIAC25 reports
- Absolute Pro 1012536-100Abbott Vascular Inc. · STENT, ILIAC21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page